CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact

CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact


CIA Director Bill Burns testifies next to Director of National Intelligence Avril Haines during a House (Select) Intelligence Committee hearing on diversity in the intelligence community, on Capitol Hill in Washington, October 27, 2021.

Elizabeth Frantz | Reuters

WASHINGTON – CIA Director William Burns tested positive for Covid-19 on Thursday, the intelligence agency said.

Burns, who is fully vaccinated and boosted against Covid-19, last met with President Joe Biden on Wednesday morning during a “socially distanced meeting and was wearing an N-95 mask.”

“Their interaction is not considered close contact as defined by CDC guidance, and Director Burns is sharing the news of his positive test out of an abundance of transparency,” the intelligence agency wrote in a statement.

Burns will continue to perform his duties as CIA director but will work from home. He will return to the office following a negative test and after isolating for five days. The agency said that Burns has experienced mild symptoms.

Burns’ positive test follows two other virus cases within Biden’s orbit.

On Sunday, White House deputy press secretary Karine Jean-Pierre said she tested positive for Covid-19. Her positive test result came several days after White House press secretary Jen Psaki tested positive for the virus, which prevented her from traveling with Biden to Belgium and Poland.

Psaki said at the time that Biden was not considered a close contact following two socially distanced meetings.

Earlier this month, second gentleman Doug Emhoff tested positive for Covid-19. Following the positive test result, the White House said that Vice President Kamala Harris would skip a scheduled event “out of an abundance of caution.”

Biden, 79, received his fourth dose of the coronavirus vaccine on Wednesday.



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More